Cite

HARVARD Citation

    Seystahl, K. et al. (n.d.). P14.108 Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma. Neuro-oncology. pp. iii93-iii94. [Online]. 
  
Back to record